BRCA2 and ovarian carcinoma: It provides further evidence that BRCA2 splicing may be regulated by factors outside the BRCA2 gene, and that a loss of coordinated splicing and BRCA2 expression by SNRPB depletion suppresses ovarian cancer cell proliferation and rescues chemotherapy response.